In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
The third part of Bollywood's iconic comedy film 'Hera Pheri' is in the headlines these days, but
Today, i.e. from December 1, many changes have taken place across the country. Now you have to pa
Maharishi Charak Shapath: The first-year MBBS students of Government Madurai Medical College took
Pakistan Politics: Future strategy for Pakistan made in London, Imran Khan's party at the center PTI
A high-profile meeting has been held in London regarding the future politics of Pakistan. This me
More than four months are left for the Uttar Pradesh assembly elections, but the war between the
Congress leader Rahul Gandhi's 'Bharat Jodo Yatra' is getting huge public support in Kerala. This
E-Waste Management As the dependence on electronic and digital services has increased in our ever
Today, the Left government was formed once again in Kerala. Pinarayi Vijayan was sworn in as the
Earthquake tremors were felt in Kutch, Gujarat, with no loss of life or property.
Earthquake tremors were felt in Kutch district of Gujarat this morning. The magnitude of the eart
Former India cricketer Gautam Gambhir has strongly criticized the culture of making a player a he
